486 N Patterson Ave., Suite 204
Our goal is to establish a hub of innovation to accelerate the research and development of novel therapeutics to prevent, treat, and cure neuropsychological disorders.
We offer our partner organizations and pharmaceutical partners access to our experimental drugs and the opportunity to access preclinical drug candidates.
The company’s initial products are Psychostimulant Addiction Therapeutics (PATs) developed by the National Institutes of Health (NIH). Our initial focus is to guide safe and effective PATs through clinical trials and into the hands of people who need them.
Be the first to know and let us send you an email when EncepHeal Therapeutics, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Contact The Business
Send a message to EncepHeal Therapeutics, Inc.: